| Revenue | 11.07M |
| Cost of revenue (1) | 5.39M |
| Gross profit | 5.68M |
| Research and development (2) | 12.62M |
| Selling, general and administrative (3) | 4.9M |
| Restructuring charges | |
| Total operating expenses | 17.52M |
| Loss from operations | -11.84M |
| Gain on sale of marketable securities | |
| Interest income and other, net | -378K |
| Loss before provision for income taxes | -12.22M |
| Provision for income taxes | 95K |
| Net loss | -12.32M |
| Basic and diluted net loss per share | -0.72 |
| Weighted average number of shares (basic and diluted) | |
| Includes stock-based compensation expense as follows: | |
| Allocated share-based compensation expense | |
| Includes stock-based compensation expense as follows: | |
| Allocated share-based compensation expense | |
| Includes stock-based compensation expense as follows: | |
| Allocated share-based compensation expense | |